EGFR-TKI for Advanced NSCLC Market Insights 2034: Advances in...

added blog Other

2026-09-15 11:15:26 -

EGFR-TKI for Advanced NSCLC Market Insights 2034: Advances in Targeted Oncology Treatments

The Global EGFR-TKI for Advanced NSCLC Market is projected to reach US$ 14.56 billion by 2034, up from US$ 7.93 billion in 2025, registering a CAGR of 7.89% during 2026–2034. The market is expanding as precision oncology becomes increasingly important in the treatment of advanced non-small cell lung cancer (NSCLC), particularly among patients whose tumors harbor...

0 Comments 0 Shares 7 Views 0 Reviews